company-logoCeriBell, Inc.$12.82
%
Analyst Rating: Hold

Stock Details

CEO

Xingjuan Chao

Sector

Healthcare

Industry

Medical - Devices

Full Time Employees

281

Address

360 North Pastoria Avenue, Sunnyvale, CA, 94085

CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.

Top Competitors

Income Statement  

Financials

Selected Year

Revenue Estimates

EPS Estimates

Net Income Estimates

Price target for CeriBell, Inc.  $12.82

EPS

Revenue

Institutional Holder

Congress Tracker 

Insider Trading of Key Employees

Financial News: CBLL